Friday, February 13, 2015
In response to ritholz (http://www.ritholtz.com/blog/2015/02/9-out-of-10-big-pharma-companies-spent-more-on-marketing-than-on-rd/) who posted an interesting piece on big pharmas Sales and marketing expense to R&D, we thought we would post a list on R&D intensive firms in the pharma sector. Here they are. One of our favorites, Cubist, was just bought by Merck in the fall. Co-incidence? We think not. Call us for more!
